RITONAVIR INHIBITS PRASUGREL IN VITRO BIOACTIVATION: A POTENTIAL PHARMACOKINETIC INTERACTION

被引：0
|
作者：
Ancrenaz, V
Daali, Y.
Samer, C.
Bosilkovska, M.
Dayer, P.
Desmeules, J.
机构：
来源：
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY | 2011年 / 109卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：150 / 150
页数：1
相关论文
共 50 条
  • [21] Pharmacokinetic interaction between fosamprenavir-ritonavir and rifabutin in healthy subjects
    Ford, Susan L.
    Chen, Ya-Chi
    Lou, Yu
    Borland, Julie
    Min, Sherene S.
    Yuen, Geoffrey J.
    Shelton, Mark J.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2008, 52 (02) : 534 - 538
  • [22] Pharmacokinetic interaction potential of duloxetine
    Waldschmitt, Christine
    Hiemke, Christoph
    Eckermann, Gabriel
    PSYCHOPHARMAKOTHERAPIE, 2009, 16 (01): : 14 - 18
  • [23] An evaluation of the potential for pharmacokinetic interaction between escitalopram and the cytochrome p450 3A4 inhibitor ritonavir
    Gutierrez, MM
    Rosenberg, J
    Abramowitz, W
    CLINICAL THERAPEUTICS, 2003, 25 (04) : 1200 - 1210
  • [24] Pharmacokinetic enhancers (cobicistat/ritonavir) and the potential for drug-drug interactions
    Hollywood, Paul
    MacCann, Rachel
    Lorigan, David
    de Barra, Eoghan
    McConkey, Samuel
    IRISH JOURNAL OF MEDICAL SCIENCE, 2020, 189 (02) : 693 - 699
  • [25] Pharmacokinetic enhancers (cobicistat/ritonavir) and the potential for drug-drug interactions
    Paul Hollywood
    Rachel MacCann
    David Lorigan
    Eoghan de Barra
    Samuel McConkey
    Irish Journal of Medical Science (1971 -), 2020, 189 : 693 - 699
  • [26] Dose separation does not overcome the pharmacokinetic interaction between fosamprenavir and lopinavir/ritonavir
    Corbett, Amanda H.
    Patterson, Kristine B.
    Tien, Hsiao-Chuan
    Kalvass, Leslie A.
    Eron, Joseph J.
    Ngo, Linh T.
    Lim, Michael L.
    Kashuba, Angela D. M.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (08) : 2756 - 2761
  • [27] Three case reports of a clinical pharmacokinetic interaction with buprenorphine and atazanavir plus ritonavir
    Bruce, RD
    Altice, FL
    AIDS, 2006, 20 (05) : 783 - 784
  • [28] Nirmatrelvir+ritonavir/tacrolimusVarious toxicities following pharmacokinetic interaction: case report
    Reactions Weekly, 2023, 1947 (1) : 320 - 320
  • [29] Possible pharmacokinetic interaction involving ritonavir and docetaxel in a patient with Kaposi's sarcoma
    Loulergue, Pierre
    Mir, Olivier
    Allali, Jerome
    Viard, Jean-Paul
    AIDS, 2008, 22 (10) : 1237 - 1239
  • [30] Pharmacokinetic drug-drug interaction analysis of pyramax® and ritonavir in healthy volunteers
    Duparc, S.
    Borghini-Fuhrer, I.
    Fleckenstein, L.
    Jung, D.
    Lopez-Lazaro, L.
    Methaneethorn, J.
    Morris, C.
    Pokorny, R.
    Shin, C. -S.
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2011, 16 : 138 - 138
12345